secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2021-08-30T23:59:59+00:00
Accession:  0000719135-21-000068
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical appoints Wendy Levine to Board of Directors
--------------------------------------------------------

- Wendy Levine appointed as a director effective August 25, 2021, expanding the Board to eight members.
- Levine will serve on the Regulatory Compliance Committee.
- She is Group President and head of advertising at 21GRAMS, part of Real Chemistry, with 25 years of healthcare marketing experience.
- Previous roles include leadership at Johnson & Johnson, Novartis Vaccines, McCann Health, and GSW.
- No arrangement with any other person led to her election; compensation follows standard director program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/0000719135-21-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/a8-kforwendy.htm
  HTML page:      https://secwatch.observer/filing/0000719135-21-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer